Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device

References

• Socialstyrelsen. Sos-rapport: Gynekologisk cellprovskontroll – Förslag till screeningprogram [The National Board of Health and Welfare. Report: Cytological Screening for Cervical Cancer – Screening Programme Suggestion] (In Swedish). Article number 1998-3–15, The National Board of Health and Welfare.
   Google Scholar
• Kumar V, Cotrans R, Robbins S. Female genital system and breast. Basic Pathology: Female Genital System and Breast. WB Saunders, Philadelphia 2003; 686–9
   Google Scholar
• Walboomers JM, Jacobs MV, Manos M, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1)12–9
   PubMed Web of Science ®Google Scholar
• Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87(11)796–802
   PubMed Web of Science ®Google Scholar
• Wright T, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 81–6
   PubMed Web of Science ®Google Scholar
• Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening. JAMA 2000; 283: 87–93
   PubMed Web of Science ®Google Scholar
• Solomon D, Schiffman M, Tarone R, ALTS Study Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293–9.
   PubMed Web of Science ®Google Scholar
• Ho L, Terry G, Londesborough P, Cuzick J, Lorenzato F, Singer A. Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears. J Med Virol 2003; 69: 118–21
   PubMed Web of Science ®Google Scholar
• Jansson Å, Gustafsson M, Wilander E. Efficiency of cytological screening for detection of cervical squamous carcinoma. Ups J Med Sci 1998; 103: 147–54
   PubMed Web of Science ®Google Scholar
• Stenkvist B, Söderstrom J. Reasons for cervical cancer despite extensive screening. J Med Screen 1996; 3(4)204–7
   PubMedGoogle Scholar
• Digene Corporation. Hybrid Capture Technology HC2. Available on WWW at: http://www.digene.com. Accessed July 20, 2005.
   Google Scholar
• Bauer H, Greer C, Manos M. Determination of genital Human papillomavirus infection by consensus PCR amplification. Diagnostic Molecular Pathology. A Practical Approach, CS Herrington, JO'D McGee. IRL Press, OxfordUK 1992; 131–52
   Google Scholar
• Applied Biosystems. AmpErase® Uracil N-glycosylase (UNG). On WWW at http://www.appliedbiosystems.com. Accessed July 20, 2005.
   Google Scholar
• Zehbe I. New Molecular Biological Methods for Detecting Human Papillomaviral Nucleic Acids in Cells and Tissue Sections. Uppsala University, Uppsala 1995; 18–29
   Google Scholar
• Brown TA. Genetics, A Molecular Approach, 2nd edition. London: Chapman & Hall, 1992: Chapter 21.
   Google Scholar
• Brown TA. Gene Cloning, 3rd edition. London: Chapman & Hall, 1995: 183–200, 228–49.
   Google Scholar
• Gunnarson R. Kappakoefficient. Department of Primary Health Care, Göteborg University – Research methodology web site. On WWW at http://infovoice.se/fou/bok/statmet/10000045.htm. Accessed December 2, 2004.
   Google Scholar
• Forslund O, Antonsson A, Edlund K, van der Brule AJ, Hansson BG, Meijer CJ, et al. Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. J Med Virol 2002; 67: 535–41
   Web of Science ®Google Scholar
• Bosch FX, de Sanjosé S, Castellsagué X, Moreno V, Muñoz N. Epidemiology of human papillomavirus infections and associations with cervical cancer: new opportunities for prevention. Papillomavirus Research: From Natural History to Vaccines and Beyond, M Saveria Campo. Caister Academic Press, England 2006; 19–39
   Google Scholar
• Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med 2001; 32: 482–91
   PubMed Web of Science ®Google Scholar
• Eaker S, Adami HO, Granath F, Wilander E, Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 346–54
   PubMed Web of Science ®Google Scholar
• Stenvall H, Wikström I, Wilander E. Human papilloma virus testing of vaginal smear obtained with a novel self-sampling device. Acta Derm Venereol 2006; 86(5)465–7
   PubMed Web of Science ®Google Scholar
• Nobbenhuis MA, Helmerhorst TJ, van der Brule AJ, Roozendaal L, Bezemer PD, Voorhorst FJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002; 55: 435–9
   PubMed Web of Science ®Google Scholar
• Gravitt PE, Lacey JV, Brinton LA, Barnes WA, Kornegat JR, Greenberg MD, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001; 10(2)95–100
   PubMed Web of Science ®Google Scholar
• Harper DM, Hildesheim A, Cobb JL, Greenberg M, Vaught J, Lorincz AT. Collection devises for human papillomavirus. J Fam Pract 1999; 48(7)531–5
   PubMed Web of Science ®Google Scholar
• Sellors JW, Lorincz AT, Mahony JB, Mielynska I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000; 163(5)513–8
   PubMed Web of Science ®Google Scholar